Oncogenic gene fusions can create neoantigens

Memorial Sloan Kettering Cancer Center researchers have identified gene fusions as a source of cancer neoantigens that could be targeted by immunotherapy.

As companies develop immunotherapies against neoantigens, research is increasingly looking beyond point mutations for sources of the tumor-specific peptides that the immune system regards as non-self (see "Alt-Neoantigens")...